- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 796.19M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $6.75B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $5.76B |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $218.2M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $245.3M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $4.12B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.26B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $9.57B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $9.17B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.94B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.25B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $7.22B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $6.17B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $18.71B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $16.79B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 773.1M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $618.5M |
| Capex | Q1 2025 · Mar 31, 2024 | $213.8M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $659.7M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.95 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.95 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $30.8M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $1.19B |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.16B |
| Revenue | Q1 2025 · Mar 31, 2024 | $2.6B |